Effects of Metformin on Microvascular Function and Exercise Tolerance in Women With Angina and Normal Coronary Arteries

Jadhav, Sachin, Ferrell, William, Greer, Ian A., Petrie, John R., Cobbe, Stuart M., Sattar, Naveed·2006·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2006.04.088

Cited by (157)

Items 101–157 of 157

  1. Metformin suppresses atherosclerosis by dampening extramedullary myelopoiesis
    Man KS Lee, Olivia D. Cooney, Yifei Zhu, Yiyu Zhang, Xuzhu Lin, Danise-Ann Onda, Sandra Galić, Bruce E. Kemp, Andrew James Murphy, Kim Loh · 2025 · American Journal of Physiology-Endocrinology and Metabolism
  2. Factor XIII Val34Leu polymorphism in patients with Cardiac Syndrome X
    Gamze Babür Güler, Ulaankhuu Batgerel, Ekrem Güler, Oğuz Karaca, Çetin Geçmen, Hacı Murat Güneş, Hicaz Zencirkıran Ağuş, Ali Metin Esen, Mehmet Muhsin Türkmen · 2013 · Cardiology Journal
  3. Ischemia with no obstructed coronary arteries and microvascular testing procedures: a review of utility, pharmacotherapy, and current challenges
    Mohammad Al Bitar, Ronney S. Shantouf, Ashraf Al Azzoni, Wael A. Almahmeed, Bassam Atallah · 2025 · Frontiers in Cardiovascular Medicine
  4. Advances in the diagnosis and management of post-percutaneous coronary intervention coronary microvascular dysfunction: Insights into pathophysiology and metabolic risk interactions
    Nan Tang, Kangming Li, Haoran Li, Q Zhang, Hao Ji, Chun-Mei Qi · 2025 · World Journal of Cardiology
  5. Koronare mikrovaskuläre Dysfunktion
    P. Ong, Udo P Sechtem · 2016 · Herz
  6. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease
    Maryam Ali Khan, Guntaj Kaur Singh, Sakina Abrar, Roshan Ganeshan, Kara Morgan, Amer Harky · 2021 · Expert Opinion on Pharmacotherapy
  7. Metformin associates with higher myocardial perfusion reserve and survival in type 2 diabetes mellitus patients
    Noor Sharrack, Kristopher D. Knott, Gaurav Singh Gulsin, Tushar Kotecha, Louise Brown, Jian L Yeo, Aldostefano Porcari, Robert Daniel Adam, Sharmaine Thirunavukarasu, Amrit Chowdhary et al. · 2024 · Scientific Reports
  8. Complex relationship between metformin and exercise in diabetes treatment: should we reconsider our recommendations?
    Normand G. Boulé · 2011 · Diabetes Management
  9. The Sick Adipocyte Theory: The Forces of Clustering at Glance
    Valmore Bermúdez, Joselyn Rojas, Miguel Aguirre, Clímaco Cano, Nailet Arráiz, Carlos Silva, Marcos Antônio Martins Lima, Raquel Cano, Eneida Fonseca, Manuel Velasco · 2011 · InTech eBooks
  10. Metformin metabolic and vascular effects in overweight/moderately obese hyperinsulinemic PCOS patients treated with contraceptive vaginal ring: a pilot study
    Elena Morotti, Paolo Giovanni Artini, Nicola Persico, Cesare Battaglia · 2019 · Gynecological Endocrinology
  11. Metformin use in gestational diabetes
    Ian W Campbell · 2020 · Elsevier eBooks
  12. Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial
    David Chen, Alicia Josephine Jenkins, Nicola Greenlaw, Katie Dudman, Tamsin Fernandes, David Carty, Alun David Hughes, Andrzej S. Januszewski, Coen D.A. Stehouwer, John R. Petrie · 2023 · Diabetes and Vascular Disease Research
  13. Targeted Therapies for Microvascular Disease
    A. Bland, Eunice Chuah, William Meere, Thomas Joseph Ford · 2023 · Cardiology Clinics
  14. Polypharmacology in Old Drug Rediscovery: Drug Repurposing
    Zhiguo Wang, Baofeng Yang · 2022 · Springer eBooks
  15. The influence of hypoglycemic drugs on exercise-mediated hypoglycemic effects in elderly type 2 diabetic patients.
    Qin Song Xu, Fengdi Wang, Yuemei Wu, Feng Li · 2015 · Europe PMC (PubMed Central)
  16. Metformin Reverses the Effects of Angiotensin 2 in Human Mammary Arteries by Modulating the Expression of Nitric Oxide Synthases
    Adrian P. Merce, Darius G. Buriman, Ana Lascu, Anca M. Bînă, Horea Bogdan Feier, Lucian Petrescu, Claudia Borza, Adrian Sturza, Danina Mirela Muntean, Octavian Marius Cretu · 2022 · Serbian Journal of Experimental and Clinical Research
  17. Metformin and Risk of New-Onset Atrial Fibrillation in Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Roopeessh Vempati, Nanush Damarlapally, Poulami Roy, Maneeth Mylavarapu, Srivatsa Surya Vasudevan, Reshma Reguram, Tanisha Vora, Hritvik Jain, Raheel Ahmed, Geetha Krishnamoorthy · 2025 · Diagnostics
  18. Microvascular Angina in Different Clinical Conditions: Diabetes and the Metabolic Syndrome
    Isabella Tritto, Cinzia Zuchi, Giuseppe Ambrosio · 2013 · Springer eBooks
  19. Microvascular angina. Modern aspects of pathogenesis, diagnostics and treatment
    A. O. Iusupova, A. A. Shendrygina, Elena V. Privalova, Yu. N. Belenkov · 2016 · Clinical Medicine (Russian Journal)
  20. Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study
    Cesare Battaglia, Bruno Battaglia, Paolo Casadio, Roberta Rizzo, Paolo Giovanni Artini · 2020 · Gynecological Endocrinology
  21. Funktionelle Herzbeschwerden
    Dirk Skowasch, Georg Nickenig · 2010 · DoctorConsult - The Journal Wissen für Klinik und Praxis
  22. Coronary Microvascular Dysfunction in Diabetes – Clinical and Research
    Guglielmo Gallone, Francesco Moroni, Marco Magnoni · 2020 · Wiley eBooks
  23. An Updated Review on Repurposing of Metformin
    Hind A. Rikabi, Dalia A. Abdulla, Mahmoud M. E. Mudawi · 2024 · Asian Journal of Pharmaceutical Research and Health Care
  24. Coronary Microvascular Dysfunction in CAD: Consequences and Potential Therapeutic Applications
    Nima Alan, Jeffrey M., Barnes Betsy · 2012 · InTech eBooks
  25. DEVELOPMENT OF TISSUE ENGINEERED SMALL DIAMETER VASCULAR GRAFT FOR THE CARDIOVASCULAR SURGERY NEEDS
    Larisa V. Antonova, Yu. А. Kudryavtseva · 2016 · Complex Issues of Cardiovascular Diseases
  26. Influence of metformin and insulin on myocardial substrate oxidation under conditions encountered during cardiac surgery
    Cyonna Holmes, LaShondra Powell, Nicholas Stanley Clarke, Michael Erik Jessen, Matthias Peltz · 2017 · Surgery
  27. Endothelial Dysfunction and Coronary Microvascular Dysfunction in Women With Angina and Nonobstructive Coronaries
    Jenna Maughan, Janet Wei, Erika Jones, C. Noel Bairey Merz, Puja K. Mehta · 2018 · Elsevier eBooks
  28. Cardiovascular Effects of Metformin
    B. T. Kurmanbekova, A. M. Noruizbaeva · 2022 · Rational Pharmacotherapy in Cardiology
  29. Progress in the Treatment of Coronary Microvascular Dysfunction
    涵 王 · 2022 · Advances in Clinical Medicine
  30. The role of astrocytes response triggered by hyperglycaemia during spinal cord injury
    Cynthia Sámano, Graciela L. Mazzone · 2023 · Archives of Physiology and Biochemistry
  31. Targeted Therapies for Microvascular Disease
    A. Bland, Eunice Chuah, William Meere, Thomas Joseph Ford · 2023 · Heart Failure Clinics
  32. Impaired Quality of Life – Causes, Assessment and Management
    Thomas R. Rutledge · 2013 · Springer eBooks
  33. New Perceptions in the Cardioprotective Effect of Metformin Against Isoproterenol Induced Cardiotoxicity in Male Rats
    Yahya Al-Qaisy, Inam Sameh Arif, Muthanna I. Al-Ezzi · 2021 · Journal Port Science Research
  34. Targeted Therapies for Microvascular Disease
    A. Bland, Eunice Chuah, William Meere, Thomas Joseph Ford · 2022 · Interventional Cardiology Clinics
  35. Microvascular Angina: Diagnosis, Assessment, and Treatment
    Angela H.E.M. Maas, Dejan Milašinović, Colin Berry, Javier Escaned · 2019 · EMJ Interventional Cardiology
  36. Systems engineering investigation into the effects of different lifestyle factors on chronic diseases
    Johanna Maria Espach · 2012
  37. Funktionelle Herzbeschwerden
    Dirk Skowasch, Georg Nickenig · 2008 · Springer eBooks
  38. Metformin and/or Exercise Training Affect Metabolic Health in Men and Women with Prediabetes
    Steven K. Malin · 2011 · ScholarWorks@UMassAmherst (University of Massachusetts Amherst)
  39. The effect of metformin on vascular function and AMP-activated protein kinase activation in Type 2 diabetes
    James Graham Boyle · 2009 · Enlighten: Theses (The University of Glasgow)
  40. Microvascular CAD: Management Issues 2014
    Manish Aggarwal · 2014
  41. Original Article The influence of hypoglycemic drugs on exercise-mediated hypoglycemic effects in elderly type 2 diabetic patients
    Qin Song Xu, Fengdi Wang, Yuemei Wu, Feng Li, Yuan Zhu · 2015
  42. The Effect of Cardiovascular Risk Factors on the Coronary Circulation
    Luis Felipe Valenzuela-García, Yasushi Matsuzawa, Amir Lerman · 2017 · Springer eBooks
  43. Koronare mikrovaskuläre Dysfunktion: Klinik, Diagnose, Therapie
    Peter Ong, Udo P Sechtem · 2016 · Herz
  44. Myocardial Small Vessel Disease and Endothelial Dysfunction
    Paul Elliott Miller · 2018 · Contemporary cardiology
  45. Cardiovascular effects of metformin on left ventricular hypertrophy in nondiabetic patients with coronary artery disease
    Mohapradeep Mohan · 2019 · Discovery Research Portal (University of Dundee)
  46. Koronare mikrovaskuläre Dysfunktion
    P. Ong, Udo P Sechtem · 2015 · Der Kardiologe
  47. Funktionelle Herzbeschwerden
    Dirk Skowasch, Georg Nickenig · 2011 · Springer eBooks
  48. Metformin associates with improved myocardial perfusion reserve and survival in patients with Type 2 Diabetes Mellitus
    Noor Sharrack, Kristopher D. Knott, Gaurav Singh Gulsin, Tushar Kotecha, Louise Brown, Jian L Yeo, Aldostefano Porcari, Robert Daniel Adam, Sharmaine Thirunavukarasu, Amrit Chowdhary et al. · 2023 · medRxiv
  49. Research Progress and Challenges of Coronary Microvascular Disease
    震 王 · 2025 · Advances in Clinical Medicine
  50. Effect of Metformin on vascular endothelial injury in patients with non-small cell lung cancer treated with chemotherapy combined with bevacizumab
    Hongyan Li, Zhenye Pu, Fang Jin · 2025 · Cancer Chemotherapy and Pharmacology
  51. Myocardial ischemia with nonobstructive coronary arteries (INOCA). Part I. The current state of INOCA problem
    D. M. Movsisyan, E. A. Komissarov, Х. Г. Алиджанова · 2025 · Medical alphabet
  52. Beyond Glycemic Control: Vascular Biologic Effects of Antidiabetic Drugs and Their Cardiovascular Promise
    Kelsey C. Muir, Christopher R. Stone, Frank William Sellke · 2025 · Reviews in Cardiovascular Medicine
  53. Drug Repurposing: Harnessing the Therapeutics from Antidiabetic Molecules
    Archana Bhatta, Priyanka Mahale, Harapriya Baral, D. K. Yuvaraj, Ravinder Kumar Kaundal · 2026 · Springer eBooks
  54. Research Progress on the Mechanisms and Treatment of Coronary Microvascular Dysfunction
    雯 乔 · 2026 · Advances in Clinical Medicine
  55. Inhibition of adenosine kinase alleviates hypertrophic cardiomyopathy by ameliorating coronary microvascular dysfunction
    Fangfang Wan, Bingxuan Ma, Ziqiang Han, Youyang Zheng, M I N J I E Lu, Jingzhou Chen, Jizheng Wang, Lei Song · 2026 · ESC Heart Failure
  56. Metformin as a potential therapeutic agent in broken heart syndrome: Targeting AMPK-dependent cardio-protection and microvascular function
    Muhannad Almubarak, Hayder Mutter Al-Kuraishy, Nawar R. Hussain, Huda Jaber Waheed, Mubarak Alruwaili, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Aya M. Mustafa, Gaber El‐Saber Batiha · 2026 · Molecular Biology Reports
  57. Functional coronary vascular disease: endotype-based classification, diagnosis, and targeted management
    Omar El Khatib, Ashraf Al Azzoni, Ronney S. Shantouf, Bassam Atallah · 2026 · Frontiers in Cardiovascular Medicine